Report for Arsenic R

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study - Pape_2020_Cancers.(Basel)_12_
Author(s) : Pape UF , Kasper S , Meiler J , Sinn M , Vogel A , Muller L , Burkhard O , Caca K , Heeg S , Buchner-Steudel P , Rodriguez-Laval V , Kuhl AA , Arsenic R , Jansen H , Treasure P , Utku N
Ref : Cancers (Basel) , 12 : , 2020
Abstract : Pape_2020_Cancers.(Basel)_12_
ESTHER : Pape_2020_Cancers.(Basel)_12_
PubMedSearch : Pape_2020_Cancers.(Basel)_12_
PubMedID: 33121007

Title : Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma - Goeppert_2019_Sci.Rep_9_4338
Author(s) : Goeppert B , Renner M , Singer S , Albrecht T , Zhang Q , Mehrabi A , Pathil A , Springfeld C , Kohler B , Rupp C , Weiss KH , Kuhl AA , Arsenic R , Pape UF , Vogel A , Schirmacher P , Roessler S , Utku N
Ref : Sci Rep , 9 :4338 , 2019
Abstract : Goeppert_2019_Sci.Rep_9_4338
ESTHER : Goeppert_2019_Sci.Rep_9_4338
PubMedSearch : Goeppert_2019_Sci.Rep_9_4338
PubMedID: 30867471
Gene_locus related to this paper: human-CES2

Title : Tissue-infiltrating plasma cells are an important source of carboxylesterase 2 contributing to the therapeutic efficacy of prodrugs - Kuhl_2016_Cancer.Lett_378_51
Author(s) : Kuhl AA , Erben U , Cieluch C , Spieckermann S , Grone J , Lohneis P , Pape UF , Arsenic R , Utku N
Ref : Cancer Letters , 378 :51 , 2016
Abstract : Kuhl_2016_Cancer.Lett_378_51
ESTHER : Kuhl_2016_Cancer.Lett_378_51
PubMedSearch : Kuhl_2016_Cancer.Lett_378_51
PubMedID: 27149931